PARP INHIBITOR
Clinical trials for PARP INHIBITOR explained in plain language.
Never miss a new study
Get alerted when new PARP INHIBITOR trials appear
Sign up with your email to follow new studies for PARP INHIBITOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Scientists test Triple-Threat attack on deadly brain cancer
Disease control OngoingThis study is testing whether adding a drug called olaparib to the standard radiation and chemotherapy treatment can help patients with aggressive, inoperable brain tumors live longer. The goal is to see if olaparib makes the cancer cells more sensitive to the damaging effects of…
Matched conditions: PARP INHIBITOR
Phase: PHASE1, PHASE2 • Sponsor: Centre Francois Baclesse • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Scientists hunt for hidden weakness in lung cancer
Knowledge-focused OngoingThis study aims to understand how common a specific DNA repair problem is in people with a certain type of advanced lung cancer (EGFR-mutated NSCLC). Researchers will look at tissue samples from 100 patients to see if having this problem is linked to how patients fare and if it m…
Matched conditions: PARP INHIBITOR
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:26 UTC